Journal
MEDICAL GAS RESEARCH
Volume 4, Issue -, Pages -Publisher
MEDKNOW PUBLICATIONS & MEDIA PVT LTD
DOI: 10.1186/2045-9912-4-5
Keywords
Anesthetic; Sevoflurane; Phosphorylation; AKT/GSK3 beta signaling pathway
Categories
Funding
- National Institutes of Health, Bethesda, Maryland [R21AG038994, R01 GM088801, R01 AG041274]
- Alzheimer's Association, Chicago, Illinois
- Cure Alzheimer's Fund, Wellesley, Massachusetts
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R01AG041274] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Background: Anesthesia with multiple exposures of commonly used inhalation anesthetic sevoflurane induces neuroinflammation and cognitive impairment in young mice, but anesthesia with a single exposure to sevoflurane does not. AKT/glycogen synthase kinase 3 beta (GSK3 beta) signaling pathway is involved in neurotoxicity and neurobehavioral deficits. However, whether sevoflurane can induce a dual effect (increase versus decrease) on the activation of AKT/GSK3 beta signaling pathway remains to be determined. We therefore set out to assess the effects of sevoflurane on AKT/GSK3 beta signaling pathway in vivo and in vitro. Methods: Six day-old wild-type mice were exposed to 3% sevoflurane two hours daily for one or three days. In the in vitro studies, H4 human neuroglioma cells were treated with 4% sevoflurane for two or six hours. We then determined the effects of different sevoflurane treatments on the levels of phosphorylated (P)-GSK3 beta(ser9) and P-AKT(ser473) by using Western blot analysis. Results: Here we show that anesthesia with 3% sevoflurane two hours daily for one day increased the levels of P-GSK3 beta(ser9) and P-AKT(ser473), but the anesthesia with 3% sevoflurane daily for three days decreased them in the mice. The treatment with 4% sevoflurane for two hours increased, but the treatment with 4% sevoflurane for six hours decreased, the levels of P-GSK3 beta(ser9) and P-AKT(ser473) in the H4 human neuroglioma cells. Conclusions: Anesthetic sevoflurane might induce a dual effect (increase versus decrease) on the activation of the AKT/GSK3 beta signaling pathway. These studies have established a system to perform further studies to determine the effects of sevoflurane on brain function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available